Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT Receptor Partial Agonist with Promotile Activity

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.13, 2002-01, pp. : 1021-1042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

By McEnroe Janet D. Fleishaker Joseph C.

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 237-246

Adis International

Access to resources Recommend Favorite

Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT 7 receptor

By Wood M. Chaubey M. Atkinson P. Thomas D.R.

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

Safety Profile of Tegaserod, a 5-HT 4 Receptor Agonist, for the Treatment of Irritable Bowel Syndrome

By Hasler W.L. Schoenfeld P.

Drug Safety, Vol. 27, Iss. 9, 2004-01 ,pp. : 619-631

Adis International

Access to resources Recommend Favorite

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT 1A receptor

By Jordan S. Koprivica V. Chen R. Tottori K. Kikuchi T. Altar C.A.

European Journal of Pharmacology, Vol. 441, Iss. 3, 2002-04 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

Tegaserod: a new 5-HT4 agonist in the treatment of irritable bowel syndrome

By Tack Jan Corsetti Maura

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1211-1218

Informa Healthcare

Access to resources Recommend Favorite